A one-year randomized double-blind, multicentre study to evaluate the effects of an oestrogen-reduced, continuous combined hormone replacement therapy preparation containing 1 mg oestradiol valerate and 2 mg dienogest on metabolism in postmenopausal women

By Endrikat Jan   Lange Evelyn   Kunz Michael   Schmidt Werner   Graeser Thomas  

The European Journal of Contraception and Reproductive Health Care, Vol. 12, Iss. 3, 2007-01 ,pp. : 229-239

Informa Healthcare

Access to resources Recommend Favorite

Hormone withdrawal-associated symptoms: Comparison of oestradiol valerate/dienogest versus ethinylestradiol/norgestimate

By Jensen Jeffrey T.  

The European Journal of Contraception and Reproductive Health Care, Vol. 18, Iss. 4, 2013-08 ,pp. : 274-283

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetics of an oral contraceptive containing oestradiol valerate and dienogest

By Zeun Susan   Lu Ming   Uddin Alkaz   Zeiler Brian   Morrison Dennis   Blode Hartmut  

The European Journal of Contraception and Reproductive Health Care, Vol. 14, Iss. 3, 2009-06 ,pp. : 221-232

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and bleeding profile of a combined oral contraceptive containing oestradiol valerate/dienogest: A pooled analysis of three studies conducted in North America and Europe

By Nelson Anita  

The European Journal of Contraception and Reproductive Health Care, Vol. 18, Iss. 4, 2013-08 ,pp. : 264-273

Informa Healthcare

Access to resources Recommend Favorite

Short-term effects of an oral contraceptive containing oestradiol valerate and dienogest on bone metabolism and bone mineral density: An observational, preliminary study

By Di Carlo Costantino   Gargano Virginia   Sparice Stefania   Tommaselli Giovanni A.   Bifulco Giuseppe   Schettino Daniela   Nappi Carmine  

The European Journal of Contraception and Reproductive Health Care, Vol. 18, Iss. 5, 2013-10 ,pp. : 388-393

Informa Healthcare

Access to resources Recommend Favorite